Barinthus Biotherapeutics (BRNS) Net Cash Flow Growth (1y) (2021 - 2026)
Barinthus Biotherapeutics (BRNS) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 198.34% |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 467.41% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -14,223.53% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 453.08% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Barinthus Biotherapeutics | 27.57 Mn | -39.54 Mn | - | 77.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.79% |
| Dec 31, 2025 | -131.07% |
| Sep 30, 2025 | 42.43% |
| Jun 30, 2025 | -53.22% |
| Mar 31, 2025 | -28.19% |
| Dec 31, 2024 | 170.55% |
| Sep 30, 2024 | -59.62% |
| Jun 30, 2024 | 40.66% |
| Mar 31, 2024 | -191.26% |
| Dec 31, 2023 | -68.99% |
| Sep 30, 2023 | -213.33% |
| Jun 30, 2023 | -90.98% |
| Mar 31, 2023 | 49.02% |
| Dec 31, 2022 | 43.21% |
| Sep 30, 2022 | 379.25% |
| Jun 30, 2022 | -111.94% |
| Mar 31, 2022 | -106.90% |
| Dec 31, 2021 | -276.94% |
| Sep 30, 2021 | -296.52% |
| Jun 30, 2021 | 8,883.03% |